Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roch Thibert

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmaceutical Research|July 24, 2002
New methods characterizing avalanche behavior to determine powder flowFrançois Lavoie, Louis Cartilier, Roch Thibert
International Journal of Pharmaceutics|June 8, 2002
Clickhaler dry powder inhaler: focussed in vitro proof of principle evaluation of a new chemical entity for asthmaRoch Thibert, Mark Parry-Billings, Martin Shott
Journal of Pharmaceutical and Biomedical Analysis|February 15, 2008
Development of a discriminating in vitro dissolution method for a poorly soluble NO-donating selective cyclooxygenase-2 inhibitorRobert Papp, Pauline Luk, Wayne M Mullett, et al.
Pharmaceutical Development and Technology|April 1, 2003
Physicochemical evaluation of carbamazepine microparticles produced by the rapid expansion of supercritical solutions and by spray-dryingPatrick Gosselin, François-Xavier Lacasse, Michel Preda, et al.
Journal of Hepatology|May 19, 2009
Evaluation of VCH-759 monotherapy in hepatitis C infectionCurtis Cooper, Eric J Lawitz, Peter Ghali, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmaceutical Research|July 24, 2002
New methods characterizing avalanche behavior to determine powder flowFrançois Lavoie, Louis Cartilier, Roch Thibert
International Journal of Pharmaceutics|June 8, 2002
Clickhaler dry powder inhaler: focussed in vitro proof of principle evaluation of a new chemical entity for asthmaRoch Thibert, Mark Parry-Billings, Martin Shott
Journal of Pharmaceutical and Biomedical Analysis|February 15, 2008
Development of a discriminating in vitro dissolution method for a poorly soluble NO-donating selective cyclooxygenase-2 inhibitorRobert Papp, Pauline Luk, Wayne M Mullett, et al.
Pharmaceutical Development and Technology|April 1, 2003
Physicochemical evaluation of carbamazepine microparticles produced by the rapid expansion of supercritical solutions and by spray-dryingPatrick Gosselin, François-Xavier Lacasse, Michel Preda, et al.
Journal of Hepatology|May 19, 2009
Evaluation of VCH-759 monotherapy in hepatitis C infectionCurtis Cooper, Eric J Lawitz, Peter Ghali, et al.
Pageof 1